findinEsegui ricerca

Novartis Venture Funds

Organisation available for the Professional Exchange Call: 2 (Aug 2013 - Oct 2013)

Type of organisation: Investment Firm 


Recommended stay period: 4-6 weeks

Novartis Venture Funds

Areas of expertise looked for:
Investment analysis, Technology assessment, Venture Investments

The Novartis Venture Funds manages over $850 million in committed capital. NVF invests in companies which have the potential to change a core therapeutic field or explore new business areas that will be critical to patient care. Our primary interest is in the development of novel therapeutics and platforms as well as medical devices, diagnostics, and delivery systems. The Funds invest for financial objectives at all stages, but prefers to invest in the early-stages of company development. With ten investment professionals located in Basel, Switzerland and Cambridge, MA the team has extensive experience in pharmaceutical R&D and venture capital.

This project has received funding from the European Union’s Seventh Programme for 
research, technological development and demonstration under grant agreement No 305128
  ENTENTE is supported by the European Commission and coordinated by Inserm-Transfert SA